Pfizer Operating Expenses 2010-2024 | PFE

Pfizer operating expenses for the twelve months ending September 30, 2024 were $54.657B, a 7.87% decline year-over-year.

  • Pfizer annual operating expenses for 2023 were $58.274B, a 10.88% decline from 2022.
  • Pfizer annual operating expenses for 2022 were $65.386B, a 5.71% increase from 2021.
  • Pfizer annual operating expenses for 2021 were $61.855B, a 85.19% increase from 2020.

Pfizer Operating Expenses 2010-2024 | PFE

  • Pfizer annual operating expenses for 2023 were $58.274B, a 10.88% decline from 2022.
  • Pfizer annual operating expenses for 2022 were $65.386B, a 5.71% increase from 2021.
  • Pfizer annual operating expenses for 2021 were $61.855B, a 85.19% increase from 2020.